Deletion of the Imprinted Phlda2 Gene Increases Placental Passive Permeability in the Mouse.
Emily AngioliniIonel SandoviciPhilip M CoanGraham J BurtonColin P SibleyAbigail L FowdenMiguel ConstânciaPublished in: Genes (2021)
Genomic imprinting, an epigenetic phenomenon that causes the expression of a small set of genes in a parent-of-origin-specific manner, is thought to have co-evolved with placentation. Many imprinted genes are expressed in the placenta, where they play diverse roles related to development and nutrient supply function. However, only a small number of imprinted genes have been functionally tested for a role in nutrient transfer capacity in relation to the structural characteristics of the exchange labyrinthine zone. Here, we examine the transfer capacity in a mouse model deficient for the maternally expressed Phlda2 gene, which results in placental overgrowth and a transient reduction in fetal growth. Using stereology, we show that the morphology of the labyrinthine zone in Phlda2-/+ mutants is normal at E16 and E19. In vivo placental transfer of radiolabeled solutes 14C-methyl-D-glucose and 14C-MeAIB remains unaffected at both gestational time points. However, placental passive permeability, as measured using two inert hydrophilic solutes (14C-mannitol; 14C-inulin), is significantly higher in mutants. Importantly, this increase in passive permeability is associated with fetal catch-up growth. Our findings uncover a key role played by the imprinted Phlda2 gene in modifying placental passive permeability that may be important for determining fetal growth.
Keyphrases
- genome wide identification
- genome wide
- copy number
- dna methylation
- genome wide analysis
- endothelial cells
- mouse model
- solid phase extraction
- transcription factor
- poor prognosis
- gene expression
- bioinformatics analysis
- weight gain
- type diabetes
- high resolution
- mass spectrometry
- wild type
- physical activity
- blood pressure
- adipose tissue
- skeletal muscle
- cerebral ischemia
- glycemic control